BUY SIDE BRO

TRANSURBAN STAPLED [TCL] TCL.AX

Latest Deep Dive · Written · AI research note

Bro's Verdict
Deep Dive

Rating

HOLD

Confidence

65%

Target Price

A$13.00

Upside

-3.8%

Horizon

medium

Transurban is a high-quality, defensive toll road franchise with inflation-linked cash flows, but at 78x NTM P/E and 22.3x NTM EV/EBITDA it trades more than two standard deviations above its own 2-year average and at a clear premium to global toll peers near 10-15x. Free cash growth is decelerating to +5.1% with consensus FY27 FCF growth of -5.1%, leverage is elevated at 270.7% debt/equity, and even generous DCF assumptions (7.5% WACC, 3% terminal growth) land below the current $65.8b enterprise value. With fair value of $13.00 roughly in line with the $13.51 price and risk/reward skewed negative, we rate it a Hold and would look to accumulate below $12.50.

Executive Summary

•Transurban trades at 78x NTM P/E and 22.3x NTM EV/EBITDA, a +2.0 SD premium to its own 2 year average, pricing in flawless delivery of a capital heavy growth pipeline.
•FY26 proportional revenue rose 6.5% to $4.05b and operating EBITDA rose 7.5% to $3.06b, yet free cash growth slowed to +5.1% and consensus FY27 FCF growth turns negative at -5.1%.
•Leverage stays elevated at 270.7% debt/equity and 0.29x net debt/EV, leaving the 4.4% distribution yield exposed to refinancing costs while rates remain restrictive.
•Recent acquisitions of additional Westlink M7, NCX and WCX interests plus entry into I-24 Tennessee extend the growth runway, but capital deployed at premium multiples dilutes near term returns on a 5.0% ROE base.

Financial Snapshot

•Revenue (TTM): $3.90b
•FY26 proportional revenue: $4.05b (+6.5% YoY)
•FY26 operating EBITDA: $3.06b (+7.5% YoY)
•FY26 free cash: $2.11b (+5.1% YoY)
•Statutory NPAT: $366m (+175.2% YoY)
•Gross margin: 62.3%
•Operating margin: 24.3%
•Net margin: 9.4%
•ROE: 5.0%
•Debt/equity: 270.7%
•Final FY26 distribution: 35.0c per security
•Dividend yield: 4.39%

Forward Outlook

•NTM EPS: $0.17 (consensus)
•NTM EPS growth: +48.0% YoY
•Consensus EBIT: $1,235.6m, EBIT growth +21.4%
•Consensus EBITDA growth: +0.9%
•Consensus FCF growth: -5.1%
•Consensus DPS: ~$0.70 annualised (two 35c payments)
•FY27 distribution guidance issued alongside the FY26 result
•Consensus target price: $14.12

Valuation Analysis

•NTM P/E: 78.1x (forward)
•TTM P/E: 85.6x (trailing)
•NTM P/S: ~14x (forward, market cap $61.29b / forward revenue ~$4.3b)
•NTM EV/EBIT: 36.6x (BF basis) vs 53.3x (Bloomberg basis)
•NTM EV/EBITDA: 22.3x vs 2 year average 12.8x (+2.0 SD, +74% vs average)
•Net debt/EV: 0.29x
•Current EV: $65.8b
•EQRV implied price at historical average P/E: $12.76
•EQRV implied price at historical average EV/EBIT: $8.34
•EQRV implied price at historical average EV/EBITDA: $5.15
•EQRV implied price at historical average P/BV: $9.67
•DCF (WACC 9%, terminal growth 2.5%, FCF $2.11b base): EV ~$34b, materially below current EV
•DCF (WACC 7.5%, terminal growth 3%): EV ~$49b, still below current EV
•Consensus target: $14.12 (+4.5% upside)
•Fair value range: $12.00 to $13.50 (midpoint ~$12.75, ~6% downside)

Peer Comparison

•ALX (Atlas Arteria): ~15x EV/EBITDA, direct toll road peer, lower leverage and higher yield
•AIA.NZ (Auckland Airport): ~20x EV/EBITDA, infrastructure duration, tourism linked volumes
•VINCI (DG.PA): ~10x EV/EBITDA, global concessions and toll roads, diversified earnings
•Ferrovial (FER): ~13x EV/EBITDA, toll road and infrastructure portfolio
•Transurban screens at a clear premium to the global toll road set on every EV based measure

Key Risks & Catalysts

Risks

•Valuation premium: 22.3x EV/EBITDA vs 12.8x 2 year average leaves no margin for execution error
•Leverage: 270.7% debt/equity and 0.29x net debt/EV amplify refinancing cost risk
•FCF growth turning negative at -5.1% consensus despite positive EBITDA growth
•Interest rate sensitivity as a bond proxy in a higher for longer rate environment
•Traffic volume risk from economic slowdown and structural work from home trends
•Regulatory risk from the NSW toll reform outcome
•Low ROE at 5.0% dilutes returns on incremental capital deployed
•Capital deployment at premium multiples across Westlink M7, NCX, WCX and I-24

Catalysts

•Completion of Westlink M7, NCX and WCX acquisitions consolidating proportional cash flows
•I-24 Southeast Choice Lanes in Tennessee opening a new US growth corridor
•NSW toll reform finalised, removing a regulatory overhang
•August 2026 traffic data showing volume growth
•FY27 distribution guidance and any index related flows
•Potential asset recycling or capital partnerships to fund the pipeline
•Rate cuts would re rate the bond proxy and compress the discount rate

Investment Thesis

Transurban is a genuinely high quality infrastructure franchise with defensive, inflation linked toll cash flows and a long dated growth pipeline. The FY26 result was solid at the operating line, with proportional revenue up 6.5% and EBITDA up 7.5%, and the acquisitions of additional Westlink M7, NCX and WCX interests plus the I-24 Tennessee entry extend the runway. The problem is price. At 78x NTM P/E and 22.3x NTM EV/EBITDA, the stock sits more than two standard deviations above its own 2 year average on the metric that matters most for a capital intensive concession operator, and at a clear premium to global toll road peers trading near 10x to 15x EV/EBITDA.

The earnings optics are distorted by heavy infrastructure depreciation, which suppresses EPS and inflates the P/E, but the cash flow picture is less forgiving. Free cash growth is decelerating to +5.1% and consensus points to -5.1% FCF growth in FY27, while leverage at 270.7% debt/equity and a 5.0% ROE leave little buffer if refinancing costs stay elevated. Our DCF, even on generous assumptions of a 7.5% WACC and 3% terminal growth, lands below the current $65.8b enterprise value, implying the market is capitalising growth well above the base case.

We rate Transurban a Hold with a fair value of $13.00, roughly in line with the current $13.51 and modestly below the $14.12 consensus target. The quality and defensive yield justify a premium to the market, but not the current extreme versus its own history and peers. Risk/reward is skewed negative at these levels, and we would look to accumulate below $12.50 where the yield and multiple re set toward more defensible ground.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Run your own analysis free

Buy Side Bro writes a note like this on any US, ASX or global stock in a few minutes: the thesis, valuation, catalysts, risks and a Buy, Hold or Sell call with a 12-month target. It comes with the daily market wrap, live markets, earnings and charts. Sign in and you get 7 days of full access free, no card needed.

iPhone app coming soon. The same account and subscription carry over.

See the latest research on other stocks